Suppr超能文献

艰难梭菌毒素中葡萄糖基转移酶的致病作用。

Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.

作者信息

Zhang Yongrong, Feng Hanping

机构信息

Department of Microbial Pathogenesis, University of Maryland Baltimore, 650 W. Baltimore Street, Baltimore, MD 21201, USA.

Department of Microbial Pathogenesis, University of Maryland Baltimore, 650 W. Baltimore Street, Baltimore, MD 21201, USA

出版信息

Pathog Dis. 2016 Jun;74(4):ftw024. doi: 10.1093/femspd/ftw024. Epub 2016 Apr 4.

Abstract

The glucosyltransferase domain ofClostridium difficiletoxins modifies guanine nucleotide-binding proteins of Rho family. It is the major virulent domain of the holotoxins. Various pathogenic effects ofC. difficiletoxins in response to Rho glucosylation have been investigated including cytoskeleton damage, cell death and inflammation. The most recent studies have revealed some significant characteristics of the holotoxins that are independent of glucosylating activity. These findings arouse discussion about the role of glucosyltransferase activity in toxin pathogenesis and open up new insights for toxin mechanism study. In this review, we summarize the pathogenic effects of glucosyltransferase domain of the toxins in the past years.

摘要

艰难梭菌毒素的葡糖基转移酶结构域修饰Rho家族的鸟嘌呤核苷酸结合蛋白。它是全毒素的主要毒性结构域。针对Rho糖基化,人们研究了艰难梭菌毒素的各种致病作用,包括细胞骨架损伤、细胞死亡和炎症。最近的研究揭示了全毒素一些与葡糖基化活性无关的重要特征。这些发现引发了关于葡糖基转移酶活性在毒素致病机制中作用的讨论,并为毒素机制研究开辟了新的思路。在本综述中,我们总结了过去几年中该毒素葡糖基转移酶结构域的致病作用。

相似文献

1
Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.
Pathog Dis. 2016 Jun;74(4):ftw024. doi: 10.1093/femspd/ftw024. Epub 2016 Apr 4.
2
Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
Toxins (Basel). 2016 Aug 15;8(8):241. doi: 10.3390/toxins8080241.
3
Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
Infect Immun. 2015 Feb;83(2):502-13. doi: 10.1128/IAI.02316-14. Epub 2014 Nov 17.
4
Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Trends Microbiol. 2008 May;16(5):222-9. doi: 10.1016/j.tim.2008.01.011. Epub 2008 Apr 18.
5
Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.
Gut Microbes. 2015 Jul 4;6(4):221-4. doi: 10.1080/19490976.2015.1062965. Epub 2015 Jun 19.
6
Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Glycobiology. 2007 Apr;17(4):15R-22R. doi: 10.1093/glycob/cwm004. Epub 2007 Jan 19.
7
The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis.
PLoS Pathog. 2020 Sep 22;16(9):e1008852. doi: 10.1371/journal.ppat.1008852. eCollection 2020 Sep.
8
Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
J Biol Chem. 2009 Feb 6;284(6):3389-95. doi: 10.1074/jbc.M806002200. Epub 2008 Dec 1.
9
Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
Cell Microbiol. 2009 Dec;11(12):1816-26. doi: 10.1111/j.1462-5822.2009.01373.x. Epub 2009 Aug 26.
10
Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.
Infect Immun. 2016 Jul 21;84(8):2317-2323. doi: 10.1128/IAI.00327-16. Print 2016 Aug.

引用本文的文献

1
Clostridioides difficile meets the adenosine system: the art of manipulating host homeostasis.
J Biomed Sci. 2025 Jul 11;32(1):66. doi: 10.1186/s12929-025-01160-8.
2
Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota.
Front Microbiol. 2024 May 24;15:1396031. doi: 10.3389/fmicb.2024.1396031. eCollection 2024.
3
Exploring the Toxin-Mediated Mechanisms in Infection.
Microorganisms. 2024 May 16;12(5):1004. doi: 10.3390/microorganisms12051004.
4
The development of live biotherapeutics against infection towards reconstituting gut microbiota.
Gut Microbes. 2022 Jan-Dec;14(1):2052698. doi: 10.1080/19490976.2022.2052698.
5
Phosphorylation and functionality of CdtR in Clostridium difficile.
Anaerobe. 2019 Aug;58:103-109. doi: 10.1016/j.anaerobe.2019.102074. Epub 2019 Jul 16.

本文引用的文献

1
The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options.
Int J Antimicrob Agents. 2015 Dec;46 Suppl 1:S47-50. doi: 10.1016/j.ijantimicag.2015.11.001. Epub 2015 Nov 3.
2
Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.
Gut Microbes. 2015 Jul 4;6(4):221-4. doi: 10.1080/19490976.2015.1062965. Epub 2015 Jun 19.
4
Identification of toxemia in patients with Clostridium difficile infection.
PLoS One. 2015 Apr 17;10(4):e0124235. doi: 10.1371/journal.pone.0124235. eCollection 2015.
5
Burden of Clostridium difficile infection in the United States.
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
8
Diagnosis and treatment of Clostridium difficile in adults: a systematic review.
JAMA. 2015 Jan 27;313(4):398-408. doi: 10.1001/jama.2014.17103.
9
Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
Infect Immun. 2015 Feb;83(2):502-13. doi: 10.1128/IAI.02316-14. Epub 2014 Nov 17.
10
The molecular basis of Clostridium difficile disease and host response.
Curr Opin Gastroenterol. 2015 Jan;31(1):24-9. doi: 10.1097/MOG.0000000000000131.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验